Convatec Group PLC (FRA:2CV)

Market Cap	5.27B
Revenue (ttm)	2.01B
Net Income (ttm)	184.52M
Shares Out	n/a
EPS (ttm)	0.09
PE Ratio	28.54
Forward PE	15.92
Dividend	0.06 (2.29%)
Ex-Dividend Date	Aug 21, 2025

Volume	n/a
Average Volume	500
Open	2.560
Previous Close	2.700
Day's Range	2.560 - 2.560
52-Week Range	2.420 - 3.520
Beta	n/a
RSI	48.96
Earnings Date	Feb 25, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory b...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1978
• Employees: 10,489
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2CV

Financial Performance

In 2024, ConvaTec Group's revenue was $2.29 billion, an increase of 6.85% compared to the previous year's $2.14 billion. Earnings were $190.50 million, an increase of 46.20%.

Financial numbers in USD